Xeris pharmaceuticals inc XERS.US Value Analysis
US StockHealth Care
(No presentation for XERS)
XERS Value Score
3
24
15
Average Growth
- AI analysis rates XERS with a medium value score of 3.
- It is mainly due to stable revenue growth, but with concerns regarding unstable operating cash flow.
- Over the past 3 months, XERS has maintained a consecutive value rating of 3.0, close to the rating of 3.0 over the past 3 years, indicating stable enterprise value.
- Compared to all stocks in the Health Care sector, XERS has a medium value rating.
XERS Value Reference Factors
The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.
Update to 2025/03/07 (Weekly Update)
XERS Financial Forecast
Unit : USD
Update to 2025/5/9 (Quarterly Update)
XERS Earnings Table
Unit : USD
| QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
|---|---|---|---|---|---|---|---|
| Current | -0.06 | 68.4% | -33.3% | 54.27M | 114.4% | 5.5% | -31.2% |
| 2024Q1 | -0.03 | 66.7% | -62.5% | 60.1M | 24.4% | 9.5% | -29% |
| 2022Q3 | -0.19 | 53.7% | -17.4% | 25.31M | 184.1% | -38.4% | -152.7% |
| 2022Q2 | -0.25 | 16.7% | 4.2% | 22.07M | 174.2% | 0% | -237% |
Update to 2025/5/10 (Quarterly Update)
XERS Historical Value Score
You can use historical scores of 3 or above to observe potential performance and make investment decisions.
XERS Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
Entry
Exit
The Backtest Result of XERS from 2018/07 till Now
- -
- Cumulative Return
- -
- Annual Return
- -
- Volatility
- -
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from July, 2018 to May, 2025. (Total Trades: 0)
| XERS | Sector | US Overall Market | |
|---|---|---|---|
| Wining Rate | - | 45% | 54% |
| Avg Return | - | 62.9% | 72.8% |
| Avg Profit | - | 197.1% | 165.9% |
| Avg Loss | - | -45.1% | -34.6% |
| Avg Risk-Reward Ratio | - | 437% | 479.2% |
Update to 2025/5/10 (Daily Update)